Current filters:  
Life Sciences, Biotechnology & Nanotechnology
Smart & Biggar
In October 2020, the Pharmaceutical Advertising Advisory Board (PAAB) released an advisory addressing references to "no sub" or "no substitution" in advertising materials.
Smart & Biggar
On October 27, 2020, the Patented Medicine Prices Review Board released the National Drug Prescription Utilization System's analytic study of the Canadian oncology market for 2010 to 2019.
Smart & Biggar
The Federal Court has released a new consolidated practice direction, Case and Trial Management Guidelines for Complex Proceedings.
Norton Rose Fulbright Canada LLP
On November 27, 2020, the Minister of Health (the Minister) issued the Interim Order Respecting Drug Shortages (Safeguarding the Drug Supply)
Torys LLP
What challenges and opportunities exist in the public procurement of pharmaceutical products and medical devices by hospitals, health authorities and group procurement organizations?
Gowling WLG
Life science companies who are in the early stages of research often ask 'how will I know if I have something patentable'.
Torys LLP
Life sciences have taken on increased importance in recent months, and are sure to be a significant part of Canada's post-pandemic economy.
G. Vrikis & Associates LLC
According to the Personal Data Protection Act, information connected to the health of an individual constitutes sensitive personal data.
European Union
Jones Day
Since the onset of the coronavirus outbreak, the European Commission has adopted a significant number of State aid measures under Article 107(2)b, Article 107(3)b and under the Temporary Framework.
Reed Smith (Worldwide)
Authors: Nicholas Rock, Adam Hedley, Annie O'Connor
Bardehle Pagenberg
Das japanische Pharmaunternehmen Daiichi Sankyo hat sich erfolgreich gegen den frühzeitigen Markteintritt generischer Wettbewerbsprodukte zu seinem erfolgreichen Arzneimittel Sevikar® gewehrt.
William Fry
The new Medical Devices Regulation (MDR) and In Vitro Diagnostic Medical Devices Regulation (IVDR) represent a long-awaited strengthening of the existing European regulatory system for medical devices.
South Africa
Adams & Adams
Biotechnologists work tirelessly to improve our quality of life. Never has this been more evident than in the current global health crisis that we face.
Gun + Partners
The outbreak of coronavirus (COVID-19), which has been declared as pandemic by the World Health Organization, has led to widespread measures being taken around the world.
Gun + Partners
An accelerated assessment procedure will be applied to applications regarding COVID-19-related clinical trials.
Moroglu Arseven
6 Ekim 2020 tarihinde, Türkiye İlaç ve Tıbbi Cihaz Kurumu ("TİTCK") "Beşeri Aşıların Klinik Dışı Değerlendirilmesine İlişkin Kılavuz"u ("Kılavuz") yayımladı. Kılavuz, ...
Moroglu Arseven
On 6 October 2020, Turkish Medicines and Medical Devices Agency ("Agency") has published "Guideline on Non-clinical Evaluation of Vaccines for Human Use" ("Guideline").
Esin Attorney Partnership
Türkiye İlaç ve Tıbbi Cihaz Kurumu ("Kurum"), COVID-19 salgınının önlenmesi ile ilgili alınan tedbirler çerçevesinde ürün tanıtım temsilcilerinin sağlık kuruluşlarına yapacağı ziyaretlerde tanıtım...
Esin Attorney Partnership
The Turkish Medicine and Medical Devices Authority ("TİTCK") announced that it re-evaluated the limitations on product promotion representatives leaving promotional materials during their visits...
Deris IP Attorneys
The Board of Advertisement has decided on July 14, 2020 for suspension of the complained advertisements with regard to "No Attack" branded products and also imposed a fine of TRY 104'781.- (for each) on the advertiser as well as individuals promoting this product through social media accounts.
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Popular Contributors
Upcoming Events
Font Size:
Mondaq Social Media